Quest Diagnostics (DGX) Other financing activities (2009 - 2026)

Quest Diagnostics has reported Other financing activities for 18 years, with the latest figure at -$25.0 million in Q2 2026.

• Quarterly Other financing activities fell 327.27% year-over-year to -$25.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.0 million (down 67.74% YoY) and the FY2025 annual result came in at $79.0 million, up 8.22% from the prior year.
• Other financing activities climbed to -$25.0 million in Q2 2026 per DGX's latest filing, from -$84.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $111.0 million in Q3 2025 and troughed at -$84.0 million in Q1 2026.
• A 5-year average of $13.2 million and a median of $16.0 million in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2024 and 2026: Other financing activities jumped 600.0% in 2024, then slumped 327.27% in 2026.
• Over 5 years, Other financing activities stood at $27.0 million in 2022, then slumped by 55.56% to $12.0 million in 2023, then jumped by 75.0% to $21.0 million in 2024, then decreased by 14.29% to $18.0 million in 2025, then plunged by 238.89% to -$25.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$25.0 million, -$84.0 million, and $18.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.